Your session is about to expire
← Back to Search
Adaptive Music Therapy for Well-being in Older Adults (AMT Trial)
N/A
Recruiting
Led By Kathryn Bolton, BA. hons
Research Sponsored by Toronto Metropolitan University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
With largely normal or corrected to normal hearing
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pretest), 4 weeks (posttest), and 16 weeks (3-month follow-up),
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing two types of music therapy on healthy older adults aged 65+. One is regular music therapy, and the other uses technology to adjust the music to improve mood. The goal is to see if these therapies can enhance mental and emotional well-being.
Who is the study for?
This trial is for healthy older adults with good or corrected hearing, no mental health diagnoses, and normal cognitive function (scoring 24+ on the Mini-Mental State Exam). Participants must have access to a computer and internet.
What is being tested?
The study tests if Pi Electronics' adaptive music intervention improves psychosocial and cognitive functions in older adults compared to traditional music therapy. It's a three-arm randomized controlled trial including pretests, posttests, and follow-ups over four weeks.
What are the potential side effects?
Since this trial involves music interventions, there are no direct physical side effects expected. However, participants may experience varying emotional responses due to the nature of therapeutic music.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My hearing is mostly normal or corrected to be normal.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (pretest), 4 weeks (posttest), and 16 weeks (3-month follow-up),
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pretest), 4 weeks (posttest), and 16 weeks (3-month follow-up),
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Activities of Daily Living: Psychosocial functions of healthy older adults.
Psychosocial Functioning
Emotional processing: Cognitive functions of healthy older adults.
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Adaptive Music Intervention (AM)Experimental Treatment1 Intervention
The intervention will be an adaptive music program, in which participants will listen to music provided by the research team that has been enhanced with frequencies that elicit positive moods using the Pi Electronic Venus speaker for 30 minutes, at least 4 times in a week over 4 weeks.
Group II: Traditional Music Intervention (TM)Active Control1 Intervention
The intervention will be traditional music therapy, in which participants will listen to music provided by the research team that has not been enhanced with frequencies using the Pi Electronic Venus speaker for 30 minutes, at least 4 times in a week over 4 weeks.
Group III: Control GroupActive Control1 Intervention
The control intervention will be an audiobook provided by the research team that participants will listen to using the Pi Electronic Venus speaker for 30 minutes, at least 4 times in a week over 4 weeks.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for executive function deficits often involve cognitive rehabilitation techniques that aim to enhance neural plasticity and improve cognitive processes. Music therapy, including adaptive music programs like Pi Electronics' AM, works by engaging multiple brain regions simultaneously, promoting neural connectivity and cognitive flexibility.
Neurofeedback, another related treatment, helps patients self-regulate brain activity, leading to improved attention and executive control. These mechanisms are crucial for executive function patients as they directly target and enhance the brain's ability to manage complex tasks, improve decision-making, and regulate behavior, ultimately leading to better psychosocial and cognitive outcomes.
Effects of music production on cortical plasticity within cognitive rehabilitation of patients with mild traumatic brain injury.
Effects of music production on cortical plasticity within cognitive rehabilitation of patients with mild traumatic brain injury.
Find a Location
Who is running the clinical trial?
Toronto Metropolitan UniversityLead Sponsor
91 Previous Clinical Trials
18,931 Total Patients Enrolled
Ryerson UniversityLead Sponsor
76 Previous Clinical Trials
7,768 Total Patients Enrolled
MitacsIndustry Sponsor
41 Previous Clinical Trials
4,356 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have not been diagnosed with a mental health condition in the past.My hearing is mostly normal or corrected to be normal.You have no dementia-related cognitive decline.You have not been diagnosed with a mental health condition before.My hearing is mostly normal or corrected to be normal.My hearing is mostly normal or corrected to be normal.
Research Study Groups:
This trial has the following groups:- Group 1: Adaptive Music Intervention (AM)
- Group 2: Traditional Music Intervention (TM)
- Group 3: Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger